BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Farmers Insurance
Moodys
Cerilliant
Covington
Mallinckrodt
Queensland Health
Julphar
Fuji
Colorcon

Generated: January 20, 2018

DrugPatentWatch Database Preview

NEBIVOLOL HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Nebivolol Hydrochloride, and what generic alternatives are available?

Nebivolol Hydrochloride is a drug marketed by Alkem Labs Ltd, Amerigen Pharms Ltd, Glenmark Pharms Ltd, Indchemie Health, and Watson Labs Inc. and is included in five NDAs.

The generic ingredient in NEBIVOLOL HYDROCHLORIDE is nebivolol hydrochloride. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the nebivolol hydrochloride profile page.
Summary for NEBIVOLOL HYDROCHLORIDE
Drug patent expirations by year for NEBIVOLOL HYDROCHLORIDE
Pharmacology for NEBIVOLOL HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for NEBIVOLOL HYDROCHLORIDE

US Patents and Regulatory Information for NEBIVOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203741-001 Jun 24, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Inc NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203683-002 Nov 27, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amerigen Pharms Ltd NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203659-003 Apr 16, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alkem Labs Ltd NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203741-004 Jun 24, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Pharms Ltd NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203821-004 May 25, 2017 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Inc NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203683-004 Nov 27, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amerigen Pharms Ltd NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203659-004 Apr 16, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Inc NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203683-003 Nov 27, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Indchemie Health NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203828-004 Jul 29, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Indchemie Health NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203828-002 Jul 29, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Mallinckrodt
Cantor Fitzgerald
Cipla
Citi
Baxter
Farmers Insurance
Chinese Patent Office
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot